Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate

Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Their roles in cell-envelope integrity have been documented in laboratory strains, and while Lpp has been linked to serum resistance , the underlying mechanism has not been established. H...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:mBio 2017-05, Vol.8 (3)
Hauptverfasser: Diao, Jingyu, Bouwman, Catrien, Yan, Donghong, Kang, Jing, Katakam, Anand K, Liu, Peter, Pantua, Homer, Abbas, Alexander R, Nickerson, Nicholas N, Austin, Cary, Reichelt, Mike, Sandoval, Wendy, Xu, Min, Whitfield, Chris, Kapadia, Sharookh B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page
container_title mBio
container_volume 8
creator Diao, Jingyu
Bouwman, Catrien
Yan, Donghong
Kang, Jing
Katakam, Anand K
Liu, Peter
Pantua, Homer
Abbas, Alexander R
Nickerson, Nicholas N
Austin, Cary
Reichelt, Mike
Sandoval, Wendy
Xu, Min
Whitfield, Chris
Kapadia, Sharookh B
description Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Their roles in cell-envelope integrity have been documented in laboratory strains, and while Lpp has been linked to serum resistance , the underlying mechanism has not been established. Here, and mutants of uropathogenic strain CFT073 showed reduced survival in a mouse bacteremia model, but only the mutant was sensitive to serum killing The peptidoglycan-bound Lpp form was specifically required for preventing complement-mediated bacterial lysis and complement-mediated clearance Compared to the wild-type strain, the mutant had impaired K2 capsular polysaccharide production and was unable to respond to exposure to serum by elevating capsular polysaccharide amounts. These properties correlated with altered cellular distribution of KpsD, the predicted outer membrane translocon for "group 2" capsular polysaccharides. We identified a novel Lpp-dependent association between functional KpsD and peptidoglycan, highlighting important interplay between cell envelope components required for resistance to complement-mediated lysis in uropathogenic isolates. Uropathogenic (UPEC) isolates represent a significant cause of nosocomial urinary tract and bloodstream infections. Many UPEC isolates are resistant to serum killing. Here, we show that a major cell-envelope lipoprotein (murein lipoprotein) is required for serum resistance and for complement-mediated bacterial clearance This is mediated, in part, through a novel mechanism by which murein lipoprotein affects the proper assembly of a key component of the machinery involved in production of "group 2" capsules. The absence of murein lipoprotein results in impaired production of the capsule layer, a known participant in complement resistance. These results demonstrate an important role for murein lipoprotein in complex interactions between different outer membrane biogenesis pathways and further highlight the importance of lipoprotein assembly and transport in bacterial pathogenesis.
doi_str_mv 10.1128/mBio.00603-17
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5442458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1902106812</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-fa542f7b60e719da007300a2a22fbaaf56de0fcfa1a0e0fa1c0f98019110c3603</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhiMEolXpkSvykUvKjLP5uiCV7dJWLKICerZmnfHGKIldO0HsX-PXkbSlAl_8SvPqmY83SV4jnCHK6l3_wbozgAKyFMtnybHEHNIyR3y-6AJTibI-Sk5j_AHzyzKsMniZHMkqzwpZw3Hy-4b9aBu37w6aBnEeo9OWRusG4Yz4PAW2g9ha73xw46Kvo_jKd5MN3Ajjgvjk40V6wZ6HhodRXAY3eSHFmnycOgrixnWHSFq3FGzDYvPLB45x4dPQiG8cpn4GRhtHGjSLuQOJ2-A8ja3b82C12ETdcrC6tSS06-w8guto5FfJC0Nd5NPH_yS5_bj5vr5Kt18ur9fn21RnVTmmhvKVNOWuAC6xbgigzABIkpRmR2TyomEw2hASzIJQg6krwBoRdDaf9iR5_8D1067nRs9rBuqUD7ancFCOrPq_MthW7d1Pla9WcpVXM-DtIyC4u4njqHobNXcdDeymqLAGiVBUKGdr-mDVwcUY2Dy1QVBL5GqJXN1HrrCc_W_-ne3J_Tfg7A84RqzU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1902106812</pqid></control><display><type>article</type><title>Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate</title><source>MEDLINE</source><source>PMC (PubMed Central)</source><source>DOAJ Directory of Open Access Journals</source><source>American Society for Microbiology Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central Open Access</source><creator>Diao, Jingyu ; Bouwman, Catrien ; Yan, Donghong ; Kang, Jing ; Katakam, Anand K ; Liu, Peter ; Pantua, Homer ; Abbas, Alexander R ; Nickerson, Nicholas N ; Austin, Cary ; Reichelt, Mike ; Sandoval, Wendy ; Xu, Min ; Whitfield, Chris ; Kapadia, Sharookh B</creator><contributor>Pier, Gerald B.</contributor><creatorcontrib>Diao, Jingyu ; Bouwman, Catrien ; Yan, Donghong ; Kang, Jing ; Katakam, Anand K ; Liu, Peter ; Pantua, Homer ; Abbas, Alexander R ; Nickerson, Nicholas N ; Austin, Cary ; Reichelt, Mike ; Sandoval, Wendy ; Xu, Min ; Whitfield, Chris ; Kapadia, Sharookh B ; Pier, Gerald B.</creatorcontrib><description>Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Their roles in cell-envelope integrity have been documented in laboratory strains, and while Lpp has been linked to serum resistance , the underlying mechanism has not been established. Here, and mutants of uropathogenic strain CFT073 showed reduced survival in a mouse bacteremia model, but only the mutant was sensitive to serum killing The peptidoglycan-bound Lpp form was specifically required for preventing complement-mediated bacterial lysis and complement-mediated clearance Compared to the wild-type strain, the mutant had impaired K2 capsular polysaccharide production and was unable to respond to exposure to serum by elevating capsular polysaccharide amounts. These properties correlated with altered cellular distribution of KpsD, the predicted outer membrane translocon for "group 2" capsular polysaccharides. We identified a novel Lpp-dependent association between functional KpsD and peptidoglycan, highlighting important interplay between cell envelope components required for resistance to complement-mediated lysis in uropathogenic isolates. Uropathogenic (UPEC) isolates represent a significant cause of nosocomial urinary tract and bloodstream infections. Many UPEC isolates are resistant to serum killing. Here, we show that a major cell-envelope lipoprotein (murein lipoprotein) is required for serum resistance and for complement-mediated bacterial clearance This is mediated, in part, through a novel mechanism by which murein lipoprotein affects the proper assembly of a key component of the machinery involved in production of "group 2" capsules. The absence of murein lipoprotein results in impaired production of the capsule layer, a known participant in complement resistance. These results demonstrate an important role for murein lipoprotein in complex interactions between different outer membrane biogenesis pathways and further highlight the importance of lipoprotein assembly and transport in bacterial pathogenesis.</description><identifier>ISSN: 2161-2129</identifier><identifier>EISSN: 2150-7511</identifier><identifier>DOI: 10.1128/mBio.00603-17</identifier><identifier>PMID: 28536290</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Animals ; Bacteremia - microbiology ; Bacterial Capsules - metabolism ; Bacterial Outer Membrane Proteins - genetics ; Bacterial Outer Membrane Proteins - metabolism ; Blood Bactericidal Activity ; Disease Models, Animal ; Escherichia coli Infections - microbiology ; Escherichia coli Proteins - genetics ; Escherichia coli Proteins - metabolism ; Lipoproteins - genetics ; Lipoproteins - metabolism ; Mice ; Microbial Viability ; Mutation ; Peptidoglycan - genetics ; Periplasmic Proteins - metabolism ; Serum - microbiology ; Uropathogenic Escherichia coli - genetics ; Uropathogenic Escherichia coli - physiology</subject><ispartof>mBio, 2017-05, Vol.8 (3)</ispartof><rights>Copyright © 2017 Diao et al.</rights><rights>Copyright © 2017 Diao et al. 2017 Diao et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-fa542f7b60e719da007300a2a22fbaaf56de0fcfa1a0e0fa1c0f98019110c3603</citedby><cites>FETCH-LOGICAL-c387t-fa542f7b60e719da007300a2a22fbaaf56de0fcfa1a0e0fa1c0f98019110c3603</cites><orcidid>0000-0002-5267-7027</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442458/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442458/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,3175,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28536290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Pier, Gerald B.</contributor><creatorcontrib>Diao, Jingyu</creatorcontrib><creatorcontrib>Bouwman, Catrien</creatorcontrib><creatorcontrib>Yan, Donghong</creatorcontrib><creatorcontrib>Kang, Jing</creatorcontrib><creatorcontrib>Katakam, Anand K</creatorcontrib><creatorcontrib>Liu, Peter</creatorcontrib><creatorcontrib>Pantua, Homer</creatorcontrib><creatorcontrib>Abbas, Alexander R</creatorcontrib><creatorcontrib>Nickerson, Nicholas N</creatorcontrib><creatorcontrib>Austin, Cary</creatorcontrib><creatorcontrib>Reichelt, Mike</creatorcontrib><creatorcontrib>Sandoval, Wendy</creatorcontrib><creatorcontrib>Xu, Min</creatorcontrib><creatorcontrib>Whitfield, Chris</creatorcontrib><creatorcontrib>Kapadia, Sharookh B</creatorcontrib><title>Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate</title><title>mBio</title><addtitle>mBio</addtitle><description>Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Their roles in cell-envelope integrity have been documented in laboratory strains, and while Lpp has been linked to serum resistance , the underlying mechanism has not been established. Here, and mutants of uropathogenic strain CFT073 showed reduced survival in a mouse bacteremia model, but only the mutant was sensitive to serum killing The peptidoglycan-bound Lpp form was specifically required for preventing complement-mediated bacterial lysis and complement-mediated clearance Compared to the wild-type strain, the mutant had impaired K2 capsular polysaccharide production and was unable to respond to exposure to serum by elevating capsular polysaccharide amounts. These properties correlated with altered cellular distribution of KpsD, the predicted outer membrane translocon for "group 2" capsular polysaccharides. We identified a novel Lpp-dependent association between functional KpsD and peptidoglycan, highlighting important interplay between cell envelope components required for resistance to complement-mediated lysis in uropathogenic isolates. Uropathogenic (UPEC) isolates represent a significant cause of nosocomial urinary tract and bloodstream infections. Many UPEC isolates are resistant to serum killing. Here, we show that a major cell-envelope lipoprotein (murein lipoprotein) is required for serum resistance and for complement-mediated bacterial clearance This is mediated, in part, through a novel mechanism by which murein lipoprotein affects the proper assembly of a key component of the machinery involved in production of "group 2" capsules. The absence of murein lipoprotein results in impaired production of the capsule layer, a known participant in complement resistance. These results demonstrate an important role for murein lipoprotein in complex interactions between different outer membrane biogenesis pathways and further highlight the importance of lipoprotein assembly and transport in bacterial pathogenesis.</description><subject>Animals</subject><subject>Bacteremia - microbiology</subject><subject>Bacterial Capsules - metabolism</subject><subject>Bacterial Outer Membrane Proteins - genetics</subject><subject>Bacterial Outer Membrane Proteins - metabolism</subject><subject>Blood Bactericidal Activity</subject><subject>Disease Models, Animal</subject><subject>Escherichia coli Infections - microbiology</subject><subject>Escherichia coli Proteins - genetics</subject><subject>Escherichia coli Proteins - metabolism</subject><subject>Lipoproteins - genetics</subject><subject>Lipoproteins - metabolism</subject><subject>Mice</subject><subject>Microbial Viability</subject><subject>Mutation</subject><subject>Peptidoglycan - genetics</subject><subject>Periplasmic Proteins - metabolism</subject><subject>Serum - microbiology</subject><subject>Uropathogenic Escherichia coli - genetics</subject><subject>Uropathogenic Escherichia coli - physiology</subject><issn>2161-2129</issn><issn>2150-7511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1v1DAQhiMEolXpkSvykUvKjLP5uiCV7dJWLKICerZmnfHGKIldO0HsX-PXkbSlAl_8SvPqmY83SV4jnCHK6l3_wbozgAKyFMtnybHEHNIyR3y-6AJTibI-Sk5j_AHzyzKsMniZHMkqzwpZw3Hy-4b9aBu37w6aBnEeo9OWRusG4Yz4PAW2g9ha73xw46Kvo_jKd5MN3Ajjgvjk40V6wZ6HhodRXAY3eSHFmnycOgrixnWHSFq3FGzDYvPLB45x4dPQiG8cpn4GRhtHGjSLuQOJ2-A8ja3b82C12ETdcrC6tSS06-w8guto5FfJC0Nd5NPH_yS5_bj5vr5Kt18ur9fn21RnVTmmhvKVNOWuAC6xbgigzABIkpRmR2TyomEw2hASzIJQg6krwBoRdDaf9iR5_8D1067nRs9rBuqUD7ancFCOrPq_MthW7d1Pla9WcpVXM-DtIyC4u4njqHobNXcdDeymqLAGiVBUKGdr-mDVwcUY2Dy1QVBL5GqJXN1HrrCc_W_-ne3J_Tfg7A84RqzU</recordid><startdate>20170523</startdate><enddate>20170523</enddate><creator>Diao, Jingyu</creator><creator>Bouwman, Catrien</creator><creator>Yan, Donghong</creator><creator>Kang, Jing</creator><creator>Katakam, Anand K</creator><creator>Liu, Peter</creator><creator>Pantua, Homer</creator><creator>Abbas, Alexander R</creator><creator>Nickerson, Nicholas N</creator><creator>Austin, Cary</creator><creator>Reichelt, Mike</creator><creator>Sandoval, Wendy</creator><creator>Xu, Min</creator><creator>Whitfield, Chris</creator><creator>Kapadia, Sharookh B</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5267-7027</orcidid></search><sort><creationdate>20170523</creationdate><title>Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate</title><author>Diao, Jingyu ; Bouwman, Catrien ; Yan, Donghong ; Kang, Jing ; Katakam, Anand K ; Liu, Peter ; Pantua, Homer ; Abbas, Alexander R ; Nickerson, Nicholas N ; Austin, Cary ; Reichelt, Mike ; Sandoval, Wendy ; Xu, Min ; Whitfield, Chris ; Kapadia, Sharookh B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-fa542f7b60e719da007300a2a22fbaaf56de0fcfa1a0e0fa1c0f98019110c3603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Bacteremia - microbiology</topic><topic>Bacterial Capsules - metabolism</topic><topic>Bacterial Outer Membrane Proteins - genetics</topic><topic>Bacterial Outer Membrane Proteins - metabolism</topic><topic>Blood Bactericidal Activity</topic><topic>Disease Models, Animal</topic><topic>Escherichia coli Infections - microbiology</topic><topic>Escherichia coli Proteins - genetics</topic><topic>Escherichia coli Proteins - metabolism</topic><topic>Lipoproteins - genetics</topic><topic>Lipoproteins - metabolism</topic><topic>Mice</topic><topic>Microbial Viability</topic><topic>Mutation</topic><topic>Peptidoglycan - genetics</topic><topic>Periplasmic Proteins - metabolism</topic><topic>Serum - microbiology</topic><topic>Uropathogenic Escherichia coli - genetics</topic><topic>Uropathogenic Escherichia coli - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Diao, Jingyu</creatorcontrib><creatorcontrib>Bouwman, Catrien</creatorcontrib><creatorcontrib>Yan, Donghong</creatorcontrib><creatorcontrib>Kang, Jing</creatorcontrib><creatorcontrib>Katakam, Anand K</creatorcontrib><creatorcontrib>Liu, Peter</creatorcontrib><creatorcontrib>Pantua, Homer</creatorcontrib><creatorcontrib>Abbas, Alexander R</creatorcontrib><creatorcontrib>Nickerson, Nicholas N</creatorcontrib><creatorcontrib>Austin, Cary</creatorcontrib><creatorcontrib>Reichelt, Mike</creatorcontrib><creatorcontrib>Sandoval, Wendy</creatorcontrib><creatorcontrib>Xu, Min</creatorcontrib><creatorcontrib>Whitfield, Chris</creatorcontrib><creatorcontrib>Kapadia, Sharookh B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>mBio</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Diao, Jingyu</au><au>Bouwman, Catrien</au><au>Yan, Donghong</au><au>Kang, Jing</au><au>Katakam, Anand K</au><au>Liu, Peter</au><au>Pantua, Homer</au><au>Abbas, Alexander R</au><au>Nickerson, Nicholas N</au><au>Austin, Cary</au><au>Reichelt, Mike</au><au>Sandoval, Wendy</au><au>Xu, Min</au><au>Whitfield, Chris</au><au>Kapadia, Sharookh B</au><au>Pier, Gerald B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate</atitle><jtitle>mBio</jtitle><addtitle>mBio</addtitle><date>2017-05-23</date><risdate>2017</risdate><volume>8</volume><issue>3</issue><issn>2161-2129</issn><eissn>2150-7511</eissn><abstract>Murein lipoprotein (Lpp) and peptidoglycan-associated lipoprotein (Pal) are major outer membrane lipoproteins in Their roles in cell-envelope integrity have been documented in laboratory strains, and while Lpp has been linked to serum resistance , the underlying mechanism has not been established. Here, and mutants of uropathogenic strain CFT073 showed reduced survival in a mouse bacteremia model, but only the mutant was sensitive to serum killing The peptidoglycan-bound Lpp form was specifically required for preventing complement-mediated bacterial lysis and complement-mediated clearance Compared to the wild-type strain, the mutant had impaired K2 capsular polysaccharide production and was unable to respond to exposure to serum by elevating capsular polysaccharide amounts. These properties correlated with altered cellular distribution of KpsD, the predicted outer membrane translocon for "group 2" capsular polysaccharides. We identified a novel Lpp-dependent association between functional KpsD and peptidoglycan, highlighting important interplay between cell envelope components required for resistance to complement-mediated lysis in uropathogenic isolates. Uropathogenic (UPEC) isolates represent a significant cause of nosocomial urinary tract and bloodstream infections. Many UPEC isolates are resistant to serum killing. Here, we show that a major cell-envelope lipoprotein (murein lipoprotein) is required for serum resistance and for complement-mediated bacterial clearance This is mediated, in part, through a novel mechanism by which murein lipoprotein affects the proper assembly of a key component of the machinery involved in production of "group 2" capsules. The absence of murein lipoprotein results in impaired production of the capsule layer, a known participant in complement resistance. These results demonstrate an important role for murein lipoprotein in complex interactions between different outer membrane biogenesis pathways and further highlight the importance of lipoprotein assembly and transport in bacterial pathogenesis.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>28536290</pmid><doi>10.1128/mBio.00603-17</doi><orcidid>https://orcid.org/0000-0002-5267-7027</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2161-2129
ispartof mBio, 2017-05, Vol.8 (3)
issn 2161-2129
2150-7511
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5442458
source MEDLINE; PMC (PubMed Central); DOAJ Directory of Open Access Journals; American Society for Microbiology Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central Open Access
subjects Animals
Bacteremia - microbiology
Bacterial Capsules - metabolism
Bacterial Outer Membrane Proteins - genetics
Bacterial Outer Membrane Proteins - metabolism
Blood Bactericidal Activity
Disease Models, Animal
Escherichia coli Infections - microbiology
Escherichia coli Proteins - genetics
Escherichia coli Proteins - metabolism
Lipoproteins - genetics
Lipoproteins - metabolism
Mice
Microbial Viability
Mutation
Peptidoglycan - genetics
Periplasmic Proteins - metabolism
Serum - microbiology
Uropathogenic Escherichia coli - genetics
Uropathogenic Escherichia coli - physiology
title Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A32%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Peptidoglycan%20Association%20of%20Murein%20Lipoprotein%20Is%20Required%20for%20KpsD-Dependent%20Group%202%20Capsular%20Polysaccharide%20Expression%20and%20Serum%20Resistance%20in%20a%20Uropathogenic%20Escherichia%20coli%20Isolate&rft.jtitle=mBio&rft.au=Diao,%20Jingyu&rft.date=2017-05-23&rft.volume=8&rft.issue=3&rft.issn=2161-2129&rft.eissn=2150-7511&rft_id=info:doi/10.1128/mBio.00603-17&rft_dat=%3Cproquest_pubme%3E1902106812%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1902106812&rft_id=info:pmid/28536290&rfr_iscdi=true